4. Sensitivity analysis ‐ quality.
Outcome | All studies | Higher quality studies |
6‐month survival | NSSD | NSSD |
12‐month survival | NSSD | NSSD |
24‐month survival | NSSD | NSSD |
Overall response | NSSD | P |
Complete response | P | P |
Toxic death | NSSD | NSSD |
Nausea and Vomiting | NP | NP |
Alopecia | NSSD | NP |
Infection | NSSD | P |
Anaemia | NSSD | NSSD |
Leukopenia | NSSD | P |
Thrombocytopenia | NP | NSSD |
Granulocytopenia | NSSD | NSSD |
NSSD ‐ No statistically significant difference between treatment groups.
P ‐ Statistically significant effect favouring platinum‐based regimens.
NP ‐ Statistically significant effect favouring non‐platinum‐based regimens.